Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions
Authors:
Open Access
- 1 August 2000
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 83 (3) , 307-310
Abstract
A previous Swedish study revealed that both prototype and variant HPV16 E6 oncoprotein, occur in about equal numbers in high-grade cervical intraepithelial neoplasia (HCIN), whereas variant HPV16 predominates in invasive cervical squamous carcinoma. Most of the malignant HPV16 variants contain a common mutation, L83V, in the E6 oncoprotein. In the present investigation, 28 HPV16 positive, invasive cervical adenocarcinomas were collected from a total number of 131 adenocarcinomas. These HPV16-positive cases were evaluated with analysis of the E6 gene, using a recently described PCR-SSCP method for identification of the specific mutation (L83V) in the E6 gene. The results obtained were correlated to findings in 103 preinvasive, HCIN, and 31 invasive cervical squamous carcinomas also infected with HPV16. The HPV16 E6 variant L83V was present in 40% of the HCIN lesions, in 54% of the invasive adenocarcinomas, in comparison to 81% of the invasive squamous carcinomas. The difference between HCIN and squamous carcinomas was statistically significant, P < 0.001, whereas the difference between HCIN and invasive adenocarcinomas was not statistically significant, P = 0.604. Prototype HPV16 and its E6 variant L83V are both prevalent in preinvasive and invasive cervical lesions in Swedish women. However, the obvious predominance of HPV16 variant in squamous carcinomas was not seen in adenocarcinomas. A single amino-acid shift in the HPV16 E6 gene appears to result in a different transforming potential in squamous and glandular cervical lesions.Keywords
This publication has 23 references indexed in Scilit:
- Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphismsThe Lancet, 1998
- Human Papillomavirus DNA in Multicentric Vulvar Intraepithelial NeoplasiaInternational Journal of Gynecological Pathology, 1998
- Nonradioisotopic Detection and Typing of Human Papillomaviruses by Use of Polymerase Chain Reaction and Single-strand Conformation PolymorphismDiagnostic Molecular Pathology, 1996
- Human Papillomaviruses and Multifocal Genital NeoplasiaInternational Journal of Gynecological Pathology, 1996
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveJNCI: Journal of the National Cancer Institute, 1995
- The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCRJournal of General Virology, 1995
- Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP analysisMolecular and Cellular Probes, 1992
- Correlation of histology and detection of human papillomavirus DNA in vulvar cancersGynecologic Oncology, 1991
- Viruses in Human CancersScience, 1991
- Diagnosis of Sickle Cell Anemia and β-Thalassemia with Enzymatically Amplified DNA and Nonradioactive Allele-Specific Oligonucleotide ProbesNew England Journal of Medicine, 1988